Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-02-19 Sale | 2026-02-23 4:55 pm | REGENERON PHARMACEUTICALS INC. | REGN | Zoghbi Huda Y Director | 1,638 | $781.33 | $1,279,812 | 2,503 (Direct) | View |
| 2024-01-02 Sale | 2024-01-04 4:11 pm | REGENERON PHARMACEUTICALS INC. | REGN | Zoghbi Huda Y Director | 1,117 | $900 | $1,005,300 | 2,989 (Direct) | View |
| 2023-10-13 Sale | 2023-10-17 4:06 pm | REGENERON PHARMACEUTICALS INC. | REGN | Zoghbi Huda Y Director | 1,000 | $850 | $850,000 | 2,364 (Direct) | View |
| 2022-03-16 Sale | 2022-03-18 4:14 pm | REGENERON PHARMACEUTICALS INC. | REGN | Zoghbi Huda Y Director | 2,000 | $675 | $1,350,000 | 3,199 (Direct) | View |
| 2021-09-13 Sale | 2021-09-15 4:03 pm | REGENERON PHARMACEUTICALS INC. | REGN | Zoghbi Huda Y Director | 1,000 | $650 | $650,002 | 10,123 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-02-19 Exercise | 2026-02-23 4:55 pm | N/A N/A | REGENERON PHARMACEUTICALS INC. | REGN | Zoghbi Huda Y Director | 1,638 | $376.69 | 2,503 (Direct) | View |
| 2026-02-19 Exercise | 2026-02-23 4:55 pm | N/A 2027-01-03 | REGENERON PHARMACEUTICALS INC. | REGN | Zoghbi Huda Y Director | 1,638 | $0 | 2,503 (Direct) | View |
| 2026-01-02 Option Award | 2026-01-06 4:21 pm | N/A 2036-01-02 | REGENERON PHARMACEUTICALS INC. | REGN | Zoghbi Huda Y Director | 2,117 | $0 | 3,665 (Direct) | View |
| 2025-01-02 Option Award | 2025-01-06 4:11 pm | N/A 2035-01-02 | REGENERON PHARMACEUTICALS INC. | REGN | Zoghbi Huda Y Director | 2,124 | $0 | 3,506 (Direct) | View |
| 2024-01-02 Option Award | 2024-01-04 4:11 pm | N/A 2034-01-02 | REGENERON PHARMACEUTICALS INC. | REGN | Zoghbi Huda Y Director | 1,742 | $0 | 2,989 (Direct) | View |
| 2024-01-02 Exercise | 2024-01-04 4:11 pm | N/A N/A | REGENERON PHARMACEUTICALS INC. | REGN | Zoghbi Huda Y Director | 1,117 | $391.92 | 2,989 (Direct) | View |
| 2024-01-02 Exercise | 2024-01-04 4:11 pm | N/A 2026-09-09 | REGENERON PHARMACEUTICALS INC. | REGN | Zoghbi Huda Y Director | 1,117 | $0 | 2,989 (Direct) | View |
| 2023-10-13 Exercise | 2023-10-17 4:06 pm | N/A N/A | REGENERON PHARMACEUTICALS INC. | REGN | Zoghbi Huda Y Director | 1,000 | $391.92 | 2,364 (Direct) | View |
| 2023-10-13 Exercise | 2023-10-17 4:06 pm | N/A 2026-09-09 | REGENERON PHARMACEUTICALS INC. | REGN | Zoghbi Huda Y Director | 1,000 | $0 | 2,364 (Direct) | View |
| 2023-01-03 Option Award | 2023-01-05 4:15 pm | N/A 2033-01-03 | REGENERON PHARMACEUTICALS INC. | REGN | Zoghbi Huda Y Director | 2,094 | $0 | 3,176 (Direct) | View |
| 2022-03-16 Exercise | 2022-03-18 4:14 pm | N/A N/A | REGENERON PHARMACEUTICALS INC. | REGN | Zoghbi Huda Y Director | 2,000 | $391.92 | 3,199 (Direct) | View |
| 2022-03-16 Exercise | 2022-03-18 4:14 pm | N/A 2026-09-09 | REGENERON PHARMACEUTICALS INC. | REGN | Zoghbi Huda Y Director | 2,000 | $0 | 3,199 (Direct) | View |
| 2022-01-03 Option Award | 2022-01-05 4:24 pm | N/A 2032-01-03 | REGENERON PHARMACEUTICALS INC. | REGN | Zoghbi Huda Y Director | 2,898 | $0 | 3,789 (Direct) | View |
| 2021-09-13 Exercise | 2021-09-15 4:03 pm | N/A N/A | REGENERON PHARMACEUTICALS INC. | REGN | Zoghbi Huda Y Director | 1,000 | $391.92 | 10,123 (Direct) | View |
| 2021-09-13 Exercise | 2021-09-15 4:03 pm | N/A 2026-09-09 | REGENERON PHARMACEUTICALS INC. | REGN | Zoghbi Huda Y Director | 1,000 | $0 | 10,123 (Direct) | View |